Medtronic (MDT)
(Real Time Quote from BATS)
$82.99 USD
+0.23 (0.28%)
Updated May 10, 2024 03:57 PM ET
4-Sell of 5 4
B Value D Growth D Momentum D VGM
Balance Sheet
Fiscal Year End for Medtronic PLC falls in the month of April.
All items in Millions except Per Share data.
4/30/2024 | 4/30/2023 | 4/30/2022 | 4/30/2021 | 4/30/2020 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 7,959 | 10,573 | 10,817 | 10,948 |
Receivables | NA | 5,998 | 5,551 | 5,462 | 4,645 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 5,293 | 4,616 | 4,313 | 4,229 |
Other Current Assets | NA | 2,425 | 2,318 | 1,955 | 2,209 |
Total Current Assets | NA | 21,675 | 23,059 | 22,548 | 22,031 |
Net Property & Equipment | NA | 5,569 | 5,413 | 5,221 | 4,828 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 3,477 | 3,403 | 3,169 | 2,832 |
Intangibles | NA | 56,269 | 56,097 | 59,701 | 58,904 |
Deposits & Other Assets | NA | 3,959 | 3,008 | 2,443 | 2,094 |
Total Assets | NA | 90,948 | 90,981 | 93,083 | 90,689 |
Liabilities & Shareholders Equity | 4/30/2024 | 4/30/2023 | 4/30/2022 | 4/30/2021 | 4/30/2020 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 2,662 | 2,276 | 2,106 | 1,996 |
Current Portion Long-Term Debt | NA | 20 | 3,742 | 11 | 2,776 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 5,530 | 5,672 | 5,957 | 5,092 |
Income Taxes Payable | NA | 840 | 704 | 435 | 502 |
Other Current Liabilities | NA | 0 | 0 | 0 | 0 |
Total Current Liabilities | NA | 9,051 | 12,394 | 8,509 | 10,366 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 708 | 884 | 1,028 | 1,174 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 24,344 | 20,372 | 26,378 | 22,021 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 5,180 | 4,610 | 5,564 | 6,256 |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 39,283 | 38,260 | 41,481 | 39,817 |
Shareholders Equity | 4/30/2024 | 4/30/2023 | 4/30/2022 | 4/30/2021 | 4/30/2020 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 24,590 | 24,566 | 26,319 | 26,165 |
Retained Earnings | NA | 30,392 | 30,250 | 28,594 | 28,132 |
Other Equity | NA | -3,317 | -2,094 | -3,311 | -3,425 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 51,665 | 52,722 | 51,602 | 50,872 |
Total Liabilities & Shareholder's Equity | NA | 90,948 | 90,981 | 93,083 | 90,689 |
Total Common Equity | 0 | 51,665 | 52,722 | 51,602 | 50,872 |
Shares Outstanding | 1,327.80 | 1,330.40 | 1,341.50 | 1,348.00 | 1,340.10 |
Book Value Per Share | 0.00 | 38.83 | 39.30 | 38.28 | 37.96 |
Fiscal Year End for Medtronic PLC falls in the month of April.
All items in Millions except Per Share data.
4/30/2024 | 1/31/2024 | 10/31/2023 | 7/31/2023 | 4/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 8,321 | 7,734 | 7,876 | 7,959 |
Receivables | NA | 5,968 | 5,934 | 5,806 | 5,998 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 5,726 | 5,754 | 5,668 | 5,293 |
Other Current Assets | NA | 2,499 | 2,658 | 2,518 | 2,425 |
Total Current Assets | NA | 22,513 | 22,081 | 21,869 | 21,675 |
Net Property & Equipment | NA | 5,838 | 5,735 | 5,665 | 5,569 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 3,599 | 3,428 | 3,461 | 3,477 |
Intangibles | NA | 54,850 | 54,881 | 55,870 | 56,269 |
Deposits & Other Assets | NA | 4,036 | 3,962 | 3,912 | 3,959 |
Total Assets | NA | 90,836 | 90,087 | 90,776 | 90,948 |
Liabilities & Shareholders Equity | 4/30/2024 | 1/31/2024 | 10/31/2023 | 7/31/2023 | 4/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 1,992 | 2,174 | 2,239 | 2,662 |
Current Portion Long-Term Debt | NA | 1,029 | 1,339 | 519 | 20 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 5,662 | 5,057 | 5,276 | 5,530 |
Income Taxes Payable | NA | 1,109 | 1,088 | 1,013 | 840 |
Other Current Liabilities | NA | 0 | 0 | 0 | 0 |
Total Current Liabilities | NA | 9,793 | 9,659 | 9,047 | 9,051 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 615 | 686 | 687 | 708 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 24,153 | 23,741 | 24,463 | 24,344 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 4,353 | 5,214 | 5,180 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 38,840 | 38,440 | 39,410 | 39,283 |
Shareholders Equity | 4/30/2024 | 1/31/2024 | 10/31/2023 | 7/31/2023 | 4/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 24,589 | 24,580 | 24,587 | 24,590 |
Retained Earnings | NA | 30,661 | 30,256 | 30,265 | 30,392 |
Other Equity | NA | -3,255 | -3,190 | -3,486 | -3,317 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 51,996 | 51,647 | 51,366 | 51,665 |
Total Liabilities & Shareholder's Equity | NA | 90,836 | 90,087 | 90,776 | 90,948 |
Total Common Equity | 0 | 51,996 | 51,647 | 51,366 | 51,665 |
Shares Outstanding | 1,327.80 | 1,327.80 | 1,329.60 | 1,330.50 | 1,330.40 |
Book Value Per Share | 0.00 | 39.16 | 38.84 | 38.61 | 38.83 |